Abstract:Pseudomonas aeruginosa can cause serious nosocomial infections. Targeting the biosynthesis of Lipid A, a major structural domain of lipopolysaccharide (LPS) in P. aeruginosa has emerged as a valuable strategy for developing novel therapeutic agents. The biosynthesis of Lipid A involves the activation of homolog enzymes including LpxA and LpxD. LpxA enzyme facilitates the transfer of R -3-hydroxydecanoic fatty acid to uridine diphosphate N -acetylglucosamine in the first step. While LPxD is accountable in third step, wherein R -3-hydroxydodecanoate is transferred to the 2′ amine of UDP-3- O -(3-hydroxydecanoyl) utilizing an ACP donor. The exploration of LpxA and LpxD has been largely neglected, as no specific small-molecule inhibitors have been identified, thus far, except for peptide inhibitors. Here, we report the identification of potential dual inhibitors of the lipid A biosynthesis pathway that target both the LpxA and LpxD enzymes as novel antibiotic agents. Among the virtually screened 32,000 marine bioactive compounds Oscillatoxin A, NCI60_041046, and LTS0192263 exhibited optimal docking interactions with LpxA and LpxD, respectively. MD simulation and MMPBSA data showcased stable interactions between selected marine products and LpxA/LpxD. FMO analysis showed that Oscillatoxin A and NCI60_041046 are the most chemically active molecules. MEP analysis data highlighted the possible electrophilic and nucleophilic distribution zones present in the structure. In addition, these bioactive molecules showed acceptable ADMET profiles. These data confirmed that Oscillatoxin A, NCI60_041046, and LTS0192263 could serve as seeds for the development of potential therapeutics to combat P. aeruginosa infection.

Small Molecule LpxC Inhibitors Against Gram-Negative Bacteria: Advances and Future Perspectives

UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.

Recent Process in the Inhibitors of UDP-3-O-(R-3-hydroxyacyl)-Nacetylglucosamine Deacetylase (lpxc) Against Gram-Negative Bacteria

LpxC inhibition: Potential and opportunities with carbohydrate scaffolds

Advance in Research on a Novel Target for the Anti-Gram Negative Bacteria Infections, Deacetylase LpxC and Its Inhibitors

Design, synthesis and evaluation of novel LpxC inhibitors containing a hydrazone moiety as Gram-negative antibacterial agents

Design, Synthesis and Structure-Activity Relationship Evaluation of Novel LpxC Inhibitors As Gram-negative Antibacterial Agents

Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens

Design,synthesis and Biological Evaluation of LpxC Inhibitors with Novel Hydrophilic Terminus

Exploring the UDP pocket of LpxC through amino acid analogs

Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.

The Complex Structure of Protein AaLpxC from Aquifex aeolicus with ACHN-975 Molecule Suggests an Inhibitory Mechanism at Atomic-Level against Gram-Negative Bacteria

Exploring marine-derived bioactive compounds for dual inhibition of Pseudomonas aeruginosa LpxA and LpxD: integrated bioinformatics and cheminformatics approaches

Disrupting Gram-negative bacterial outer membrane biosynthesis through inhibition of the lipopolysaccharide transporter MsbA.

Bacterial Zinc Metalloenzyme Inhibitors: Recent Advances and Future Perspectives

TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against Enterobacteriaceae

Discovery of Dual-Activity Small-Molecule Ligands of Pseudomonas Aeruginosa LpxA and LpxD Using SPR and X-ray Crystallography.

Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity

Exploration of the structure-activity relationship and druggability of novel oxazolidinone-based compounds as Gram-negative antibacterial agents.

Optimization Of Globomycin Analogs As Novel Gram-Negative Antibiotics

A comprehensive review of recent developments in the gram-negative bacterial UDP-2,3-diacylglucosamine hydrolase (LpxH) enzyme